Cargando…

Small cell oesophageal carcinoma: an institutional experience and review of the literature

Primary small cell oesophageal carcinoma (SCOC) is rare, prognosis is poor and there is no established optimum treatment strategy. It shares many clinicopathologic features with small cell carcinoma of the lung; therefore, a similar staging and treatment strategy was adopted. Sixteen cases referred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hudson, E, Powell, J, Mukherjee, S, Crosby, T D L, Brewster, A E, Maughan, T S, Bailey, H, Lester, J F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360086/ https://www.ncbi.nlm.nih.gov/pubmed/17299393 http://dx.doi.org/10.1038/sj.bjc.6603611

Ejemplares similares

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
por: Cox, S, et al.
Publicado: (2016)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado: (2017)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice
por: Loffeld, R. J. L. F., et al.
Publicado: (2013)

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers
por: Wu, C, et al.
Publicado: (2015)

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma
por: Kurashige, J, et al.
Publicado: (2012)

Staging investigations for oesophageal cancer: a meta-analysis
por: van Vliet, E P M, et al.
Publicado: (2008)

Sex hormones and oesophageal adenocarcinoma: influence of childbearing?
por: Lagergren, J, et al.
Publicado: (2005)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
por: Hurt, C N, et al.
Publicado: (2017)

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
por: Chhabra, Arpit, et al.
Publicado: (2015)

Combined modality chemoradiation in elderly oesophageal cancer patients
por: Anderson, S E, et al.
Publicado: (2007)

Support vector machine-based nomogram predicts postoperative distant metastasis for patients with oesophageal squamous cell carcinoma
por: Yang, H X, et al.
Publicado: (2013)

Actual Incidence and Clinical Behaviour of Follicular Thyroid Carcinoma: An Institutional Experience
por: De Crea, Carmela, et al.
Publicado: (2014)

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands
por: van Vliet, E P M, et al.
Publicado: (2006)

Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis
por: van Vliet, E P M, et al.
Publicado: (2007)

Hiatus Hernia Repair with Bilateral Oesophageal Fixation
por: Mendis, Rajith, et al.
Publicado: (2015)

Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
por: Reeh, Matthias, et al.
Publicado: (2017)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

Functional Magnetic Resonance in the Evaluation of Oesophageal Motility Disorders
por: Covotta, Francesco, et al.
Publicado: (2011)

Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature
por: Su, Shan-shan, et al.
Publicado: (2016)

Three-Dimensional-Printed Model-Assisted Management of Craniovertebral Junction Abnormalities: An Institutional Experience with Literature Review
por: Agarwal, Prashant, et al.
Publicado: (2020)

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
por: Conroy, T, et al.
Publicado: (2010)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial
por: Verschuur, E M L, et al.
Publicado: (2009)

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
por: Millar, J, et al.
Publicado: (2005)

Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer
por: Chiarion-Sileni, V, et al.
Publicado: (2007)

Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of Mexico
por: Stankov, A., et al.
Publicado: (2012)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer
por: Day, F L, et al.
Publicado: (2011)

The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
por: Okumura, H, et al.
Publicado: (2005)

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2007)

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
por: de Boer, A G E M, et al.
Publicado: (2002)

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response
por: Gillham, C M, et al.
Publicado: (2006)

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer
por: McKernan, M, et al.
Publicado: (2008)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2015)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2006)

Primary small cell oesophageal carcinoma: A retrospective study of different ‎treatment modalities
por: Alfayez, Mohammad
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tc1n7b212t33qh4ep30ghsjcmo